Neurology Minute

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 88:31:06
  • More information

Informações:

Synopsis

From the editors of the Neurology Journal, Neurology Minute is a daily 1-2 minute brief podcast delivering a quick, practical rundown of what you need to know in neurology. Neurology Minute is hosted by Dr. Stacey Clardy, with contributions by leading neurologists and neuroscientists.

Episodes

  • Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS

    Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS

    29/10/2026 Duration: 03min

    Dr. Zohaib Siddiqi and Dr. Michel Toledano discuss the diagnosis and management of infectious rhombencephalitis in patients receiving immunomodulatory therapy. Show citation: Trentadue T, Martinez Sosa S, Itoh CY, et al. Clinical Reasoning: A 30-Year-Old Female Patient With Multiple Sclerosis Presenting With Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia. Neurology. 2025;105(12):e214429. doi:10.1212/WNL.0000000000214429 

  • Optimizing Management of Episodic Cluster Headache

    Optimizing Management of Episodic Cluster Headache

    28/10/2026 Duration: 02min

    Dr. Tesha Monteith shares practical tips for improving outcomes for patients with episodic cluster headache.

  • Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Adults with Migraine

    Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Adults with Migraine

    27/10/2026 Duration: 02min

    Dr. Tesha Monteith discusses growing evidence supporting CGRP-targeted therapies as first-line preventive treatment options for people with migraine. Show citation:  Reuter U, Dycke AV, Versijpt J, et al. Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial. Lancet Neurol. 2026;25(9):806-817. doi:10.1016/S1474-4422(26)00214-0 

  • Rethinking Seronegative NMOSD

    Rethinking Seronegative NMOSD

    26/10/2026 Duration: 02min

    Dr. Casey Kozak discusses why most patients referred with seronegative NMOSD ultimately receive alternative diagnoses, underscoring the challenges of accurate diagnosis in antibody-negative cases.  Show citation: Lang MV, Welk GM, Tajfirouz DA, et al. Unveiling Misdiagnosis: Rethinking Seronegative NMOSD. Mult Scler. 2025;31(11):1381-1384. doi:10.1177/13524585251360648 

  • The Menopause Transition and Epilepsy

    The Menopause Transition and Epilepsy

    22/10/2026 Duration: 01min

    Dr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife. Show citation:  Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:10.1212/CPJ.0000000000200650

  • TRUE-MOGAD Score

    TRUE-MOGAD Score

    21/10/2026 Duration: 02min

    Dr. Casey Kozak discusses a new scoring system for MOGAD identification.  Show citation: Vilaseca A, Filippatou AG, Said Y, et al. TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results. Neurol Neuroimmunol Neuroinflamm. 2026;13(5):e200617. doi:10.1212/NXI.0000000000200617 

  • Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers

    Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers

    20/10/2026 Duration: 03min

    Dr. Hailey Katulski discusses limb compression therapy and chemotherapy-induced peripheral neuropathy in women with gynecologic cancers.  Show citation: Başkurt K, Uyar GC, Yeşilbaş E, et al. Limb Compression Therapy and Chemotherapy-Induced Peripheral Neuropathy in Women With Gynecologic Cancers: A Prospective Self-Controlled Study(NEURO-GLOVE Trial). Int J Cancer. 2026;159(9):2300-2313. doi:10.1002/ijc.70601 

  • Delusional Misidentification Syndromes - Part 9

    Delusional Misidentification Syndromes - Part 9

    19/10/2026 Duration: 03min

    In the final episode of this nine-part series, Dr. Christine Cliatt-Brown discusses pharmacologic and non-pharmacologic management. 

  • Herpes Zoster Vaccination and Incident Dementia in Canada

    Herpes Zoster Vaccination and Incident Dementia in Canada

    16/10/2026 Duration: 02min

    Dr. Margarita Fedorova and Dr. Pascal Geldsetzer discuss how the herpes zoster vaccination may have neuroprotective effects, potentially delaying or preventing dementia. Show citation:  Pomirchy M, Chung S, Bommer C, Strobel S, Geldsetzer P. Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. Lancet Neurol. 2026;25(2):170-180. doi:10.1016/S1474-4422(25)00455-7 

  • Understanding the Forces Shaping US Health Care

    Understanding the Forces Shaping US Health Care

    15/10/2026 Duration: 02min

    Dr. Jason Crowell and Dr. John McDonough discuss the historical and economic factors shaping the US healthcare system and why understanding these systemic forces matters for neurologists and patient care.  Show citation:  Powell A. How to fix U.S. Healthcare? "Radical Action," says John McDonough. Harvard Gazette. August 18, 2026. Accessed August 20, 2026. https://news.harvard.edu/gazette/story/2026/08/how-to-fix-u-s-healthcare-radical-action-says-john-mcdonough/.   

  • Delusional Misidentification Syndromes - Part 8

    Delusional Misidentification Syndromes - Part 8

    14/10/2026 Duration: 02min

    In the eighth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses delusional companion syndrome. 

  • Delusional Misidentification Syndromes - Part 7

    Delusional Misidentification Syndromes - Part 7

    13/10/2026 Duration: 02min

    In the seventh episode of this nine-part series, Dr. Christine Cliatt-Brown discusses reduplicative paramnesia. 

  • Delusional Misidentification Syndromes - Part 6

    Delusional Misidentification Syndromes - Part 6

    12/10/2026 Duration: 02min

    In the sixth episode of this nine-part series, Dr. Christine Cliatt-Brown discusses Cotard syndrome. 

  • Prevalence of CTE at Death in National Football League Players

    Prevalence of CTE at Death in National Football League Players

    09/10/2026 Duration: 01min

    Dr. Shuvro Roy and Dr. Daniel Daneshvar discussed the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia.  Show citation:  Daneshvar DH, Nowinski CJ, Abdolmohammadi B, et al. Prevalence of chronic traumatic encephalopathy at death in National Football League players: retrospective population based cohort study, 2008-21. BMJ. 2026;394:e100418. Published 2026 Aug 25. doi:10.1136/bmj-2026-100418 

  • Clinical Manifestations of Primary CNS T-Cell Lymphoma

    Clinical Manifestations of Primary CNS T-Cell Lymphoma

    08/10/2026 Duration: 01min

    Dr. Kait Nevel and Dr. Katharina Schmidbauer discuss primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease.  Show citation: Schmidbauer KJ, Karschnia P, Kaulen LD, et al. Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features. Neurol. 2026;106(7):e214744. Published 2026 Mar 17. doi:10.1212/WNL.0000000000214744

  • October 2026 President Spotlight: One AAN Community

    October 2026 President Spotlight: One AAN Community

    07/10/2026 Duration: 03min

    In the October episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss updates on membership options that will help more neurology professionals connect with the AAN.  Stay informed by watching the President's Spotlight video.  

  • The Future of Child Neurology Residency Training - Part 2

    The Future of Child Neurology Residency Training - Part 2

    06/10/2026 Duration: 02min

    In part two of this series, Dr. Dara Albert and Dr. Bruce Cohen highlight the most important takeaways from the task force findings.  Show citation:  Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331 

  • Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 2

    Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 2

    05/10/2026 Duration: 01min

    In the second episode of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim discuss key take-home messages from the guideline recommendations and share insights on integrating them into clinical practice.  Show citation:  Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199 

  • The Future of Child Neurology Residency Training - Part 1

    The Future of Child Neurology Residency Training - Part 1

    02/10/2026 Duration: 02min

    In part one of this series, Dr. Dara Albert and Dr. Bruce Cohen discuss why the Child Neurology Society felt it was important to establish a task force to examine child neurology training at this point in time.  Show citation:  Cohen BH, Gilbert DL, Xixis K, et al. Education Research: The Future of Child Neurology Residency Training: The Perspective of a Child Neurology Society Task Force. Neurol Educ. 2026;5(2):e200331. Published 2026 Jun 12. doi:10.1212/NE9.0000000000200331 

  • Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 1

    Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations - Part 1

    01/10/2026 Duration: 01min

    In the first part of this two-part series, Dr. Tesha Monteith and Dr. Tamara Pringsheim provide a brief overview of the guideline recommendations for pharmacologic treatment of migraine prevention in adults.  Show citation:  Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Headache. Published online August 31, 2026. doi:10.1111/head.70199 

page 1 from 102